InsidersTradesSigma
Follow the 제테마 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 제테마 has published 121 reports. Market capitalisation: €155bn. The latest transaction was filed on 3 July 2026 (Purchase). Among the most active insiders: 박종우. Every trade is openly available.
121
Insider Decl.
n/a
Thresholds
€277,791
27 ops.
Buy Volume
€4m
15 ops.
Sell Volume
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,181 of 28,797 companies
24.5
score / 100
Value22
Quality27
FCF yld-2.5%
Earn yld-3.4%
EV/EBITDA27.1x
ROE-8.2%
Gross mgn48%
Net mgn-8.6%
Debt/EBITDA10.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2026
Declarations121 total
25 of 121 declarations
About 제테마
제테마 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.